Bryan Huntley

By proton-admin | June 13, 2018

“Currently, I am in watch and wait mode much to the dismay of my wife and family. Unfortunately, paying for proton therapy out of-pocket would impose an enormous financial burden on my family that we cannot bear.”


As the owner of a family business, I’ve spent decades working to build the highest quality products and provide superior service to my customers. Unfortunately, when I was diagnosed with prostate cancer in early 2017, I was shocked to discover that my insurance company doesn’t share the same values.

After my diagnosis, I was determined to treat my cancer head on. When my doctors recommended radical removal of my prostate, I wasn’t completely on board with that approach. Then I was recommended for proton therapy and became convinced it was the right treatment for me. Compared to traditional radiation, proton therapy carried a much lower risk of urinary and sexual side effects over the long-term.

I called my insurer and was told my proton therapy would be highly considered for approval if the hospital could prove this was the best treatment plan. Since some of the best doctors in the country prescribed it, I felt confident that my insurance company would pay for it.

I was horrified when my insurer started denying my claims. After 3 denials and countless hours spent worrying about my health, my case went in front of the Insurance Review Board of the state of Michigan. I hired an attorney to help me but was ultimately told that proton therapy was deemed to be medically unnecessary and experimental.

Currently, I am in watch and wait mode much to the dismay of my wife and family. I am having quarterly blood tests drawn to verify if the cancer has become aggressive or is still at bay. I have decided that radical removal is simply not an option. Unfortunately, paying for proton therapy out of-pocket would impose an enormous financial burden on my family that we cannot bear.

This just isn’t right. It’s time for insurance companies to do their job and pay for the cancer treatments their customers need.